https://www.curelabveterinary.com/university-of-camerino-signs-strategic-partnership-with-curelab-veterinary-to-revolutionize-cancer-treatment-for-companion-animals/2022-05-06T13:31:09-04:00https://www.curelabveterinary.com/curelab-veterinary-secures-patent-protection-for-p62-plasmid-therapeutic-in-south-korea/2022-05-06T14:08:22-04:00https://www.curelabveterinary.com/curelab-veterinarys-dna-plasmid-elenavet-designated-a-biologic-veterinary-product-by-the-european-medicines-agency/2022-05-12T10:20:54-04:00https://www.curelabveterinary.com/review-paper-published-by-curelab-veterinary-and-university-of-camerino-shows-additional-opportunities-for-use-of-elenavet-in-treating-domestic-animals/2022-05-19T09:36:18-04:00https://www.curelabveterinary.com/curelab-research-results-with-cats-published-in-animals-journal/2022-09-15T05:10:46-04:00https://www.curelabveterinary.com/biotech-internship-opportunity-fda-usda-liaison/2022-11-06T10:24:09-05:00https://www.curelabveterinary.com/curelab-receives-3m-from-prominent-biotech-investor-dr-john-ballantyne/2023-03-03T19:02:41-05:00https://www.curelabveterinary.com/curelab-oncology-secures-patent-protection-for-p62-plasmid-therapeutic-in-india/2023-07-16T17:46:27-04:00https://www.curelabveterinary.com/curelab-seeks-new-strategic-partners-to-bring-cancer-innovation-to-market/2023-09-29T11:42:57-04:00https://www.curelabveterinary.com/curelab-oncology-secures-patent-protection-in-canada-for-elenagen-its-p62-plasmid-cancer-therapeutic/2024-03-26T19:33:56-04:00https://www.curelabveterinary.com/healing-by-proxy-newly-discovered-drug-elenagen-may-treat-cancer-and-inflammation-through-indirect-action/2024-06-30T11:20:25-04:00https://www.curelabveterinary.com/curelab-oncology-files-patent-application-for-groundbreaking-wound-healing-therapy/2024-09-23T13:25:00-04:00https://www.curelabveterinary.com/curelab-veterinary-appoints-seasoned-industry-leader-alexis-nahama-dvm-as-executive-advisor/2024-08-09T18:50:50-04:00https://www.curelabveterinary.com/curelab-veterinary-announces-15-million-regulation-d-offering-to-advance-cancer-and-inflammatory-disease-treatments-for-pets/2024-11-12T05:54:39-05:00https://www.curelabveterinary.com/curelab-ceo-dr-alexander-shneider-unveils-promising-cancer-treatment-at-2024-medinvest-conference/2024-11-22T11:34:13-05:00https://www.curelabveterinary.com/curelab-oncologys-elenagen-dna-vaccine-shows-promise-in-immuno-oncology-and-beyond/2024-11-12T05:59:00-05:00https://www.curelabveterinary.com/curelab-oncology-seeks-to-revolutionize-chronic-pain-management-with-novel-p62-based-therapy/2025-06-18T04:29:12-04:00https://www.curelabveterinary.com/curelab-veterinarys-elenavet-gene-therapy-delivers-90-success-in-pet-dog-osteoarthritis-study/2025-08-12T09:49:48-04:00https://www.curelabveterinary.com/could-a-stem-cell-arthritis-treatment-for-dogs-work-in-humans-pain-news-network-explores-elenagens-promise/2025-08-12T10:44:22-04:00https://www.curelabveterinary.com/investigational-anti-cancer-dna-therapy-eases-chronic-osteoarthritis-pain-in-dogs-pointing-to-a-new-non-opioid-path-for-humans/2025-08-12T11:29:00-04:00